Oxurion NV (XBRU:OXUR) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Oxurion NV Change In Payables And Accrued Expense?

Oxurion NV's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was €0.00 Mil. It means Oxurion NV's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Dec. 2023 .

Oxurion NV's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €0.00 Mil. It means Oxurion NV's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Oxurion NV Change In Payables And Accrued Expense Historical Data

The historical data trend for Oxurion NV's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Change In Payables And Accrued Expense Chart

Oxurion NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Oxurion NV Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Oxurion NV Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Oxurion NV Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxurion NV (XBRU:OXUR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (XBRU:OXUR) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

TG4:Germany

Address

Gaston Geenslaan 1, Leuven, BEL, B-3001

Website

https://www.oxurion.com

Oxurion NV is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME). The Group's research and development facilities are located in Belgium .The Company is engaged in the development of drugs to treat back-of-the-eye diseases, more specifically, ophthalmologic pharmaceuticals to treat vascular retinal disorders, specifically DME.

Oxurion NV (XBRU:OXUR) Headlines

No Headlines